×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
LS02 Quality Control in the E6(R3) Era: What Should the Quality-Control Process Emphasize?
Session Chair(s)
Katsuhiko Sawada, MPharm
Director, Research and Development Dept.
Otsuka Medical Devices Co.Ltd., Japan
Speaker(s)
Satoko Sakai
Satoko Sakai
Idorsia Pharmaceuticals Japan Ltd., Japan
Manager of Clinical Quality Management
TOMONORI ABE, MSc
TOMONORI ABE, MSc
Linical Co., Ltd., Japan
Associate Manager
Yuko Kageyama, MT
Yuko Kageyama, MT
Ministry of Health, Labour and Welfare Government of Japan, Japan
Research and Development Policy Division